Hemispherian Competitors and Similar CompaniesClear all
Hemispherian's competitors and similar companies include Xencor and AstraZeneca.
 Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 2015 | Founding Date 1997 | Founding Date 1999 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Oslo, NO HQ | Locations Pasadena, US HQ San Diego, US | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more |
Employees | Employees 10 | Employees 2604% increase | Employees 94,300 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 b | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $125.6m (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) |
Net income | Net income N/A | Net income ($92.1m) (FY, 2025) | Net income $10.2b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 9.8m | Total funding raised $ 108.4m | Total funding raised $ 1b |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company